Sana Biotechnology SANA Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's other noncash income (expense)?
- Sana Biotechnology (SANA) reported other noncash income (expense) of $2.62M in Q1 2026.
- How has Sana Biotechnology's other noncash income (expense) changed year-over-year?
- Sana Biotechnology's other noncash income (expense) decreased by 20.1% year-over-year, from $3.27M to $2.62M.
- What is the long-term trend for Sana Biotechnology's other noncash income (expense)?
- Over 4 years (2021 to 2025), Sana Biotechnology's other noncash income (expense) has grown at a 37.4% compound annual growth rate (CAGR), from $3.08M to $10.98M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.